1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Eric Thompson, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens 5-day TMZ, 21-day TMZ, PEP-CMV: Component A - Glioblastoma, Glioblastoma Multiforme | Phase 1 | Terminated | Eric Thompson, M.D. | 27 | 2016-12-07 | 2022-06-09 |
Glioblastoma (1)
Temozolomide (1) · Tetanus Toxoid (1)
United States (1)
David Ashley, MBBS, FRACP, PhD (1)
R42CA153845 (1)